跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG
Approved
STANDARD
NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG
Eugia Pharma (Malta) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 15, 2025
Approval ID
2da665bd7cb22215
Company
Eugia Pharma (Malta) Limited
Type
Standard
Approval Details
Approval Id
2da665bd7cb22215
Drug Cima Aemps Name
NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG
Register Number
90026
Holder Company Name
Eugia Pharma (Malta) Limited
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2025-01-15
Dosage Form
CÁPSULA BLANDA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Eugia Pharma (Malta) Limited
Active Ingredients
NINTEDANIB ESILATO
120,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 15, 2025
Approval ID
2da665bd7cb22215
Type
Standard
Back to CIMA-AEMPS Approvals
NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
